Muhammad Khalid Zafar, MD

Commentary

Potential Interactions of Remdesivir With Psychotropics

May 28, 2020

The FDA has approved remdesivir for severe COVID-19 in children and adults. This commentary reviews potential interactions of remdesivir with psychotropic medications.

Letter to the Editor

Pimavanserin: A 2019 Clarification on the FDA Update

December 26, 2019

The authors of this letter to the editor comment on a previously published report on pimavanserin in The Primary Care Companion for CNS Disorders.